October 17, 2023
Astellas Pharma said on October 16 that it has obtained the blessing of a key European regulatory panel for Veoza (fezolinetant) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, known as hot flashes or night...read more